We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Vertex Phase III Results Promising for Cystic Fibrosis Treatment
Vertex Phase III Results Promising for Cystic Fibrosis Treatment
March 2, 2011
Vertex Pharmaceuticals says it is on track for a second half NDA filing for VX-770, an oral treatment for cystic fibrosis (CF), after it released positive results from its Phase III STRIVE trial Feb. 23.